OmniAb Inc. (OABI)
OABI trades on Nasdaq in Health Care, Biotechnology: Commercial Physical & Biological Resarch. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.70
-1.47% on the day
Market cap
$683.3M
Small cap
Revenue · 2025
$18.7M
-29.3% on 2024
Net income · 2025
-$64.8M
-347.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | OABI on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001846253 |
| SEC industry code | Services-Commercial Physical & Biological Research |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $18.7M |
| Net income | -$64.8M |
| Operating income | -$69.0M |
| Net margin | -347.0% |
| Operating margin | -369.5% |
| Revenue growth | -29.3% |
| Cash | $25.5M |
| Total assets | $300.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 36.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2025-09-12 |
| Latest annual report | 10-K | 2026-03-04 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-08-06 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 384 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +1.0% |
| 1 month | +5.9% |
| 3 months | +125.7% |
| Year to date | +148.9% |
| 1 year | +184.3% |
| From 52-week high | -8.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| OABIW | OmniAb Inc. Warrant | $0.2835 |
Peers in Biotechnology: Commercial Physical & Biological Resarch
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NRC | NRC Health | $20.17 | -1.18% | $446.2M |
| ABSI | Absci Corporation | $9.10 | -5.89% | $1.6B |
| MXCT | MaxCyte Inc. | $0.9643 | -3.08% | $99.5M |
| ICLR | ICON plc | $164.34 | -0.04% | $12.6B |
| CRL | Charles River Laboratories International Inc. | $299.02 | -0.94% | $14.3B |
| MEDP | Medpace Holdings Inc. | $609.89 | -1.64% | $17.0B |
| ONMD | OneMedNet Corp | $4.02 | +2.29% | $24.2M |
| INCY | Incyte Corp. | $108.62 | -2.46% | $22.0B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier